Industry Payments to PIs Should Be Revealed to Study Subjects

Clinical Trials Advisor
A A
Possible conflicts of interest, such as industry payments to a clinical investigator for running trials, should be disclosed to trial participants during the informed consent process, a group of trial experts says.

To View This Article:

Login

Subscribe To Clinical Trials Advisor